Safety and short-term efficacy of preoperative FOLFOX therapy in patients with resectable esophageal squamous cell carcinoma who are ineligible for cisplatin
ConclusionsPreoperative FOLFOX had a manageable safety profile and showed favorable short-term efficacy in patients with resectable LAESCC who were ineligible for CDDP-containing treatment.
Source: Esophagus - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Docetaxel | Eloxatin | Esophagus Cancer | Gastroenterology | Japan Health | Pneumonia | Skin Cancer | Squamous Cell Carcinoma | Study | Taxotere | Toxicology